A detailed history of Summit Global Investments transactions in Rx Sight, Inc. stock. As of the latest transaction made, Summit Global Investments holds 8,437 shares of RXST stock, worth $283,989. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,437
Previous 10,440 19.19%
Holding current value
$283,989
Previous $628,000 33.6%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$40.78 - $57.04 $81,682 - $114,251
-2,003 Reduced 19.19%
8,437 $417,000
Q2 2024

Jul 22, 2024

BUY
$50.42 - $64.29 $526,384 - $671,187
10,440 New
10,440 $628,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $930M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.